Comparison

Aloperine European Partner

Item no. S2420-500
Manufacturer Selleckchem
CASRN 56293-29-9
Amount 500 mg
Quantity options 1 g 50 mg 500 mg
Category
Type Inhibitors
Specific against other
Smiles C1CCN2CC3CC(C2C1)C=C4C3NCCC4
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Others
Similar products Aloperine
Available
Storage Conditions
2 years -80 in solvent
Molecular Weight
232, 36
Administration
Topical application
Animal Models
Female BALB/c mice with DNFB-induced allergic contact dermatitis
Cell lines
K562, U937, HL-60, EC109, A549 and HepG2
Concentrations
Dissolved in DMSO, final concentrations ca.2 mM
Dosages
1% (w/w)
Formulation
Mixed in the emollient cream vehicle
In vitro
Compared with other alkaloids including sophoridine, sophocarpine, matrine, oxymatrine and cytisine, Aloperine treatment exerts the most potent cytotoxic activity against human cancer cell lines of differing tissue origins, including leukaemia cell lines HL-60, U937 and K562, oesophageal cancer EC109 cells, lung cancer A549 cells and the hepatocellular carcinoma HepG2 cell line with IC50 of 0.04 mM, 0.27 mM, 0.36 mM, 1.11 mM, 1.18 mM, and 1.36 mM, respectively. The strongest cytotoxic effect of Aloperine on HL-60 cells is observed at 72 hours with the inhibition rate of 94.1%.In contrast to the effect on leukaemia cells, up to 1 mM of Aloperine does not significantly reduce the viability of normal PBMNCs at 72 hours. Aloperine treatment at 20 uM for 48 hours significanlty induces apoptosis and autophagy in HL-60 cells in a dose-dependent manner. [2]
In vivo
Topical application of 1% Aloperine suppresses 2, 4-dinitrofluorobenzene (DNFB)-induced increase in ear thickness and ear erythema in BALB/c mice, and significantly decreases the up-regulated mRNA and protein levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta) and interleukin-6 (IL-6) induced by DNFB in ear biopsy homogenates. [1] Topical application of Aloperine reduces the DNFB-induced dermatitis (dermatitis index and ear thickness) in NC/Nga mice at day 13 and day 14 in a dose-dependent manner. Aloperine treatment reduces DNFB-induced lymphocytes infiltration and eosinophils infiltration in a dose-dependent manner. Aloperine treatment also reduces the DNFB-induced infiltration of mast cells in a dose-dependent manner., Aloperine reduces the plasma level of IgE in a dose-dependent manner. Aloperine markedly reduces DNFB-induced increase in IL-4, IL-13 and IFN-gamma productions, while it increases the IL-10 level in a dose-dependent manner. Aloperine treatment significantly reduces the cytokine levels of TNF-alpha, IL-1beta and IL-6 in ear biopsies homegenates of NC/Nga mice in a dose-dependent manner. [3]
Incubation Time
24, 48, and 72 hours
Method
Cells are seeded in 96-well plates in 100-uL culture medium. After incubation of 4 hours for leukaemia cells and of 24 hours for solid cancer cells, experimental media containing either excipient control or Aloperine are added to appropriate wells. Five concentrations of Aloperine for 48-hour treatment are used to determine the in vitro IC50 growth inhibitory values of Aloperine in cancer cells. After incubation, 10 uL of MTT solution (5 mg/mL) is added to each well. The plates are then incubated for 4 hours at 37 C. Intracellular formazan crystals are dissolved by addition of 100 uL of isopropanol-HCI-SDS solution to each well. After an overnight incubation at 37 C, the optical density of the samples is determined at 570 nm. DNA fragmentation is analysed after the extraction of DNA from cells exposed to the indicated doses of Aloperine for 48 hours using apoptotic DNA ladder kit. For autophagy detection, cells are collected and incubated with PBS containing 5 uM acridine orange for 15 minutes. The acridine orange is removed and the cells are resuspended in 100 uL of PBS. Fluorescent micrographs are obtained with an inverted fluorescent microscope. Autophagy is quantified based on the mean number of cells displaying intense red staining for three fields (containing at least 50 cells per field) for each experimental condition.
Solubility (25C)
DMSO 2 mg/mL, Water <1 mg/mL, Ethanol 46 mg/mL
Information
Aloperine is an isolated alkaloid in sophora plants such as Sophora alopecuroides L, and exhibits anti-inflammatory, antibacterial, antiviral, and anti-tumor properties.
Chemical Name
6, 13-Methano-2H-dipyrido[1, 2-a:3', 2'-e]azocine, 1, 3, 4, 6, 6a, 7, 8, 9, 10, 12, 13, 13a-dodecahydro-, (6R, 6aR, 13R, 13aS)-

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?